Stefan Dercon, Albert Park, Abhijeet Singh, 25 June 2012

Despite the popularity of school meals, little evidence exists on their effect on health outcomes. This study investigates whether the school meals program in Andhra Pradesh, India, ameliorated the deterioration of health in young children caused by a severe drought.

Peter Diamond, 02 September 2011

Nobel laureate Peter Diamond of MIT talks to Romesh Vaitilingam about of the impact of improved longevity and the resulting demographic change on the retirement and healthcare systems of the advanced economies. The interview was recorded in August 2011 at the Fourth Lindau Meeting on Economic Sciences, which brought together 17 of the 38 living economics laureates with nearly 400 top young economists from around the world. [Also read the transcript]

Timothy Hatton, 05 August 2011

The last century has seen dramatic improvements in the health of Europeans. Young adult males are about 11 centimetres taller than their counterparts were a century ago. This column examines and explains the remarkable long-run trends in the average height of Europeans.

Lucian Cernat, 24 July 2011

Malaria is still a public-health nightmare in many African countries. This column argues for greater coherence between trade, foreign investment, and other malaria-related policy initiatives. In particular, technical assistance should prioritise the removal of "killer tariffs" on mosquito nets.

Amanda Goodall, 21 July 2011

Are hospitals better run by former doctors or by specialist managers? This column looks at the top-ranking hospitals in the US and finds that hospital-quality scores are about 25% higher in physician-run hospitals than in the average hospital.

James Banks, Zoë Oldfield, James P Smith, 21 July 2011

How much of our health in adulthood and old age is determined by our childhood? Using decades of data from the US and England, this column shows that the US excess in disease is common throughout the age distribution of the population. Moreover, poor childhood health tends to worsen adult health more in the US.

Joan Costa-i-Font, Nebibe Varol, Alistair McGuire, 08 July 2011

Pharmaceutical price regulations make drugs more accessible to consumers – if the products are brought to market. This column explores how price regulation affects the diffusion of pharmaceutical treatments. It finds that more regulated, lower-price markets experience the longest delays in launching new medications.

Anupam Jena, Jonathan Skinner, Amitabh Chandra, 19 June 2011

How much healthcare to provide and how to pay for it are two questions at the heart of the public sector. This column argues that by using comparative effectiveness research, policymakers can better understand those healthcare initiatives that work and those that do not. In doing so, the research can give rise to the often-cited but rarely-seen efficiency gains.

Friedrich Breyer, Stefan Felder, Joan Costa-i-Font, 14 May 2011

Over the last half century, life expectancy in the industrialised world has risen dramatically – and so has the healthcare bill. Is population ageing the main reason? This column argues that while ageing does affect health spending, it is far less important than many think. It adds that obsession with an ageing population is a dangerous red herring that prevents dealing with the real culprits of rising costs.

Carol Propper, 11 February 2011

Britain’s coalition government is proposing significant healthcare reforms, which include promoting greater competition between providers and changing the way that care is commissioned. Carol Propper of the Centre for Market and Public Organisation talks to Romesh Vaitilingam about the evidence for some of the claims and counterclaims about the likely impact of the reforms. The interview was recorded at the University of Bristol in February 2011. [Also read the transcript]

Martin Gaynor, Carol Propper, 23 August 2010

Governments faced with rising costs and growing demand are constantly searching for methods of delivering higher productivity in healthcare. This column suggests that the introduction of competition among UK hospitals – yet with a fixed price – has lowered death rates without a commensurate increase in costs.

Eric Sun, Anupam Jena, Tomas Philipson , Darius Lakdawalla, Carolina Reyes, Dana Goldman, 11 January 2010

US healthcare costs are under scrutiny. Americans have spent billions of dollars on cancer research in recent decades. Has it paid off? This column says that investments in cancer research and development have been quite worthwhile – producing a value to society far in excess of costs.



Vox Talks


CEPR Policy Research